Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Escalon Medical Corp. (ESMC) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$3.86M
Net Income	$1.01M
Cost of Goods Sold	$1.91M
Gross Profit	$1.95M
Operating Expenses	$3.29M
Operating Income	$0.57M
Non-Operating Income/Expense	$0.07M
Pre-Tax Income	$0.64M
Normalized Pre-Tax Income	$-2.17M
Income after Taxes	$1.78M
Income from Continuous Operations	$1.78M
Consolidated Net Income/Loss	$1.78M
Normalized Income after Taxes	$0.08M
EBIT	$0.57M
EBITDA	$0.57M
Weighted-Average Shares Outstanding (Basic)	7.42M
Weighted-Average Shares Outstanding (Diluted)	14.60M
Earnings per Share (EPS) (Basic)	$0.13
Earnings per Share (EPS) (Diluted)	$0.13
Balance Sheet Financials
Current Assets	$7.01M
Property, Plant, and Equipment	$0.03M
Long-Term Assets	$2.12M
Total Assets	$9.13M
Current Liabilities	$2.39M
Long-Term Debt	$0.14M
Long-Term Liabilities	$0.81M
Total Liabilities	$3.20M
Common Equity	$5.28M
Tangible Shareholders Equity	$5.92M
Shareholders Equity	$5.93M
Common Shares Outstanding	7.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.40M
Cash Flow from Investing Activities	$2.80M
Cash Flow from Financial Activities	$-0.13M
Beginning Cash	$0.80M
End Cash	$3.07M
Increase/Decrease in Cash	$2.26M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.94
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.02
Gross Margin	50.41%
Operating Margin	14.73%
EBIT Margin	14.73%
EBITDA Margin	--
Pre-Tax Profit Margin	16.63%
Profit Margin	26.29%
Free Cash Flow	$-0.41M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.42
Inventory Turnover	1.10
Receiveable Turnover	2.03
Days Sales in Receivables	44.37
Return on Equity	33.72%
Return on Tangible Equity	30.09%
Return on Assets	19.52%
Return on Investments	29.38%
Book Value Per Share	$0.80
Free Cash Flow per Share	$-0.03
Operating Cash Flow per Share	$-0.03

Data from Zacks Investment Research, Inc.